Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PBRM1 | Q86U86 | 1/20 | 0.63 |
| ▸ | PARP1 | P09874 | 9/20 | 0.61 |
| ▸ | F2 | P00734 | 1/20 | 0.59 |
| ▸ | PLG | P00747 | 1/20 | 0.59 |
| ▸ | PRSS1 | P07477 | 1/20 | 0.59 |
| ▸ | PRSS2 | P07478 | 1/20 | 0.59 |
| ▸ | PRSS3 | P35030 | 1/20 | 0.59 |
| ▸ | POLB | P06746 | 2/20 | 0.54 |
| ▸ | TSHR | P16473 | 2/20 | 0.54 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.54 |
| ▸ | RECQL | P46063 | 2/20 | 0.54 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.54 |
| ▸ | MAPT | P10636 | 1/20 | 0.54 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.54 |
| ▸ | BLM | P54132 | 1/20 | 0.54 |
| ▸ | PMP22 | Q01453 | 1/20 | 0.54 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.54 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.54 |
| ▸ | NPC1 | O15118 | 1/20 | 0.53 |
| ▸ | MITF | O75030 | 1/20 | 0.53 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| 3-Aminobenzamide SCHEMBL27679552 | 1.00 | PBRM1 (0.63) | PBRM1PARP1F2PLGPRSS1 | |
| 3-Aminobenzamide SCHEMBL8688920 | 0.98 | F2 (0.63) | PBRM1PARP1F2PLGPRSS1 | |
| 3-Aminobenzamide SCHEMBL28015741 | 0.98 | PBRM1 (0.61) | PBRM1PARP1F2PLGPRSS1 | |
| 3-Aminobenzamide SCHEMBL28944114 | 0.98 | PBRM1 (0.61) | PBRM1PARP1F2PLGPRSS1 | |
| SCHEMBL2909580 | 0.93 | PARP1 (0.59) | PBRM1PARP1F2PLGPRSS1 | |
| 3-Aminobenzamide SCHEMBL28759683 | 0.92 | PBRM1 (0.60) | PBRM1PARP1F2PLGPRSS1 | |
| Terephthalic Acid SCHEMBL28053568 | 0.90 | PBRM1 (0.58) | PBRM1PARP1F2PLGPRSS1 | |
| 3-Aminobenzamide SCHEMBL27579659 | 0.88 | PARP1 (0.81) | PBRM1PARP1F2PLGPRSS1 | |
| SCHEMBL3790485 | 0.87 | ERN1 (0.54) | PBRM1PARP1F2PLGPRSS1 | |
| 3-Aminobenzamide SCHEMBL10277410 | 0.87 | PBRM1 (0.55) | PBRM1PARP1F2PLGPRSS1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Appears in 6656 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3594323-B1 | METHODS AND COMPOSITIONS FOR GENERATING PANCREATIC PROGENITORS AND FUNCTIONAL BETA CELLS FROM HPSCS | UNIV HEALTH NETWORK (CA) | 2026-05-27 | — | — | EP | claimed |
| US-12637510-B2 | Oncolytic virus compositions and methods for the treatment of cancer | CITY OF HOPE (US) | 2026-05-26 | — | — | US | claimed |
| EP-4739310-A1 | ECTONUCLEOTIDE PYROPHOSPHATASE/PHOSPHODIESTERASE 1 (ENPP1) INHIBITOR COMBINATIONS AND USES THEREOF | Insilico Medicine IP Limited (HK) | 2026-05-13 | — | — | EP | claimed |
| US-20260108619-A1 | CONJUGATION LINKERS, CELL BINDING MOLECULE-DRUG CONJUGATES CONTAINING THE LINKERS, METHODS OF MAKING AND USES SUCH CONJUGATES WITH THE LINKERS | HANGZHOU DAC BIOTECH CO., LTD. (CN) | 2026-04-23 | — | — | US | claimed |
| US-12576124-B2 | Formulation of a conjugate of a tubulysin analog to a cell-binding molecule | HANGZHOU DAC BIOTECH CO., LTD (CN) | 2026-03-17 | — | — | US | claimed |
| US-20260027126-A1 | COMBINATION THERAPY FOR TREATING CANCERS | GEISTLICH PHARMA AG (CH) | 2026-01-29 | — | — | US | claimed |
| US-20250339551-A1 | AN ANTIBODY-DRUG CONJUGATE HAVING TWO OR MORE DIFFERENT FUNCTIONAL SMALL MOLECULES FOR ENHANCED TREATMENT OF REFRACTORY DISEASES | HANGZHOU SEEHE BIOTECHNOLOGY CO., LTD (CN) | 2025-11-06 | — | — | US | claimed |
| US-20250340879-A1 | COMPOSITIONS AND METHODS FOR NUCLEIC ACID TRANSFER | CHILDRENS HOSPITAL MED CT (US) | 2025-11-06 | — | — | US | claimed |
| EP-4642492-A1 | AN ANTIBODY-DRUG CONJUGATE HAVING TWO OR MORE FUNCTIONAL SMALL MOLECULE COMPOUNDS FOR ENHANCED TREATMENT OF REFRACTORY DISEASES | Hangzhou Seehe Biotechnology Co., Ltd (CN) | 2025-11-05 | — | — | EP | claimed |
| EP-4642484-A1 | TARGETED TREATMENT OF PROSTATE CANCERS AND OTHER TUMORS BY AN ANTIBODY-DRUG CONJUGATE | Hangzhou Seehe Biotechnology Co., Ltd (CN) | 2025-11-05 | — | — | EP | claimed |
| US-5516941-A | OXIDIZING 3-AMINOBENZAMIDE TO 3-NITROSOBENZAMIDE; VIRICIDES; ANTICARCINOGENIC AND ANTITUMOR AGENTS | OCTAMER, INC. (US) | 1996-05-14 | — | — | US | claimed |
| WO-1995034680-A1 | METHOD TO IDENTIFY TUMOR SUPPRESSOR GENES | THE TRUSTEES OF COLUMBIA UNIVERSITY IN THE CITY OF NEW YORK (US) | 1995-12-21 | — | — | WO | claimed |
| EP-0672250-A1 | A NOVEL $i(IN VITRO) METHOD OF SCREENING POTENTIAL ANTICANCER DRUGS USING A CELL DIFFERENTIATION ASSAY | PROCYON BIOPHARMA INC. (CA) | 1995-09-20 | — | — | EP | claimed |
| EP-0612240-A4 | METHOD FOR EXTENDING THE VASCULAR DWELL-TIME OF PARTICULATE THERAPEUTIC AND PARTICULATE DIAGNOSTIC AGENTS. | LONG DAVID M JR (US) | 1995-05-17 | — | — | EP | claimed |
| EP-0612240-A1 | METHOD FOR EXTENDING THE VASCULAR DWELL-TIME OF PARTICULATE THERAPEUTIC AND PARTICULATE DIAGNOSTIC AGENTS | Long, David M., Jr. (US) | 1994-08-31 | — | — | EP | claimed |
| WO-1994000758-A1 | A NOVEL IN VITRO METHOD OF SCREENING POTENTIAL ANTICANCER DRUGS USING A CELL DIFFERENTIATION ASSAY | VETROGEN CORPORATION (CA) | 1994-01-06 | — | — | WO | claimed |
| WO-1993009762-A2 | METHOD FOR EXTENDING THE VASCULAR DWELL-TIME OF PARTICULATE THERAPEUTIC AND PARTICULATE DIAGNOSTIC AGENTS | LONG DAVID M JR (US) | 1993-05-27 | — | — | WO | claimed |
| EP-0531370-A1 | INHIBITION OF VIRAL INFECTION. | COLLINS MARY KATHARINE LEVINGE (GB) | 1993-03-17 | — | — | EP | claimed |
| WO-1991018591-A1 | INHIBITION OF VIRAL INFECTION | COLLINS MARY KATHARINE LEVINGE (GB) | 1991-12-12 | — | — | WO | claimed |
| US-4970297-A | CONTAINING ISOXAZOLE RING | SYNTEX (U.S.A.) INC. (US) | 1990-11-13 | — | — | US | claimed |